Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Harvard Business School
Colorcon
Medtronic
Moodys
AstraZeneca
Boehringer Ingelheim

Last Updated: November 20, 2019

DrugPatentWatch Database Preview

Litigation Details for Smithkline Beecham v. Pentech Phar Inc (N.D. Ill. )

See Plans and Pricing

« Back to Dashboard

Small Molecule Drugs cited in Smithkline Beecham v. Pentech Phar Inc
The small molecule drugs covered by the patents cited in this case are   Start Trial and   Start Trial .

Details for Smithkline Beecham v. Pentech Phar Inc (N.D. Ill. )

Date Filed Document No. Description Snippet Link To Document
2003-05-08 359 plaintiffs and the identical patent. The patent (U.S. patent 4,721,723_“723” for short) is for crystalline…agreement is not limited to patent 723 but embraces every SmithKline patent that might be a basis for charging… ) Defendornts. OPINION* These consolidated patent infringement suits were as- signed to me under …) because of their close relation to a previous patent infringement suit that had been assigned to and…hydrochloride, in capsule form, that in- fringes patent 723. The active ingredient for Pentech’s drug is External link to document
2001-02-16 68 Beecham Group, p.l.c. owns U.S. Patent No. 4,721,723 (“the ‘723 patent”) for an invention entitled “Anti-Depressant…Corporation owns U.S. Patent Nos. 5,872,132 (“the ‘132 patent”) and 5,900,423 (“the ‘423 patent”) for inventions…use, or sell a patented product or a product the use of which is patented before the patent expires Pentech…Pharmaceuticals, Inc. (“Pentech”) for patent infringement Smithkline’s patents cover certain crystalline forms…are unique to patent law. "[A] procedural issue that is not itself a substantive patent law issue is External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Dow
AstraZeneca
Merck
Colorcon
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.